The global cell counting market is
expected to reach USD 1.7 billion by 2025, according to a new report by Grand
View Research, Inc. Government initiatives working to promote development of
cell therapeutics, wherein cell counting plays an imperative role, is expanding
growth prospects for the market. As a result of extensive R&D activities,
the number of diseases treated with the help of stem cells increased to 82 in
2016 from 27 in 2005. Also, California Institute for Regenerative Medicine’s
funding of USD 271 million for stem cell therapy created 12 R&D facilities
in California, and these facilities brought approximately USD 543 million
funding. In addition, it is also funded by National Institutes of Health (NIH),
which approximately invested USD 1,429 million in 2015.
Increase in
the number of collaborations of research institutes with various public and
private entities to promote R&D has provided significant boost to the
market. Growing number of proposed guidelines and recommendations for public
and private laboratories to ensure high-quality standards and facilitate
generation of accurate results are likely to improve adoption of instruments
over the coming years. For instance, in May 2016, the International Society for
Stem Cell Research updated guidelines for the development of cell-based therapy
and research. The proposed guidelines focus on all stages of R&D and
improve quality of preclinical studies.
Browse full report by
Grand View Research : http://www.grandviewresearch.com/industry-analysis/cell-counting-market
Further Key Findings From the Report Suggest:
·
Spectrophotometers accounted forthe largest
market share in 2016. This can be attributed to high penetration in various
applications such as toxicology studies, bioprocessing, and others
·
Automated counters were anticipated to grow
at an exponential rate during the forecast period. Benefits such as short
testing time, reduced error occurrence, and interoperator variability are
expected to further increase demand for automated counters
·
In the end-use segment, research and
academic institutes accounted for the largest market share in 2016, owing to
growing number of government initiatives focused toward promoting R&D in
various toxicology studies
·
Research and academic institutes are also
expected to witness exponential growth opportunities, owing to the growing
adoption of instruments for optimum drug concentration in therapeutics
·
North America held the largest share of the
market, owing to increase in number of supportive initiatives to fund R&D,
which is anticipated to result in higher adoption of automated instruments
·
Asia Pacific is anticipated to grow with a
lucrative CAGR during the forecast period. This lucrative growth rate is a
consequence of improvements in testing facilities
·
Level of competition is high as key players
are adopting strategies such as new product development and strategic
collaborations & agreements to gain competitive advantage
Browse more reports of this category by
Grand View Research: https://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the
global cell counting market on the basis of product, end use, and region:
Cell Counting
Product Outlook (Revenue, USD Million, 2014 - 2025)
·
Instruments
o
Spectrophotometers
o
Flow Cytometers
o
Hematology Analyzers
o
Cell Counters
·
Consumables & Accessories
o
Reagents
o
Microplates
o
Others
Cell
Counting End-use Outlook (Revenue, USD Million, 2014 - 2025)
·
Hospitals & Diagnostic Laboratories
·
Research & Academic Institutes
·
Pharmaceutical & Biotechnology
Companies
·
Others
Cell
Counting Regional Outlook (Revenue, USD Million, 2014 - 2025)
·
North America
o
U.S.
o
Canada
·
Europe
o
UK
o
Germany
o
France
o
Italy
o
Spain
·
Asia Pacific
o
Japan
o
China
o
India
·
Latin America
o
Brazil
o
Mexico
·
Middle East & Africa
o
South Africa
o
Saudi Arabia
View press
release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-cell-counting-market
About Grand
View Research
Grand View Research, Inc. is a U.S. based market research and consulting
company, registered in the State of California and headquartered in San
Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
